SCHEMBL17485992

SCHEMBL17485992

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)C4CCC5C4)nc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GLA P06280 1/20 0.40
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
CNR2 P34972 1/20 0.38
CHRNB2 P17787 2/20 0.36
CHRNA3 P32297 2/20 0.36
KDM1A O60341 4/20 0.36
MAOB P27338 1/20 0.35
HPGDS O60760 2/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA7 P36544 1/20 0.35
CHRNA4 P43681 1/20 0.35
NTSR1 P30989 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19295148 0.85 NPC1 (0.38) ALDH1A1MAPTHPGDLMNAHSD17B1
SCHEMBL16905550 0.83 HSD17B1 (0.49) HSD17B1HSD17B2CNR2CHRNB2CHRNA3
SCHEMBL19295158 0.81 L3MBTL1 (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL17486307 0.80 CNR2 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19295166 0.77 ADORA2A (0.32)
SCHEMBL16905553 0.77 HSD17B1 (0.45) HSD17B1HSD17B2CHRNB2CHRNA3KDM1A
SCHEMBL20805515 0.77 CYP11B1 (0.35)
SCHEMBL19295072 0.76 HSD17B1 (0.34) HSD17B1HSD17B2KDM1AMAOB
SCHEMBL22197106 0.76 MEN1 (0.55) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL15615049 0.75 SIGMAR1 (0.33) HSD17B1HSD17B2CHRNB2CHRNA3KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 MEN1 989/4885KMT2A 2922/4885ALDH1A1 3721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.